MedPath

Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans

Not Applicable
Completed
Conditions
Overweight and Obesity
Interventions
Behavioral: Late Time-Restricted Feeding
Behavioral: Early Time-Restricted Feeding
Registration Number
NCT04351672
Lead Sponsor
German Institute of Human Nutrition
Brief Summary

This human dietary intervention study with a cross-over design aims to compare the effects of two isocaloric diets - early time-restricted feeding (TRF) vs. late TRF - on glycemic control and lipid metabolism in overweight and obese women.

Detailed Description

The participants are randomly allocated to one of two study groups: In study group (A) participants will begin with the early TRF (e-TRF) intervention. They will consume their habitual food (and the habitual daily amount of food) between 8 am and 4 pm for two weeks. After a washout-phase participants will conduct the late TRF (l-TRF) and consume their habitual food between 1 pm and 9 pm for another two weeks. Study group (B) receives the same interventions in the reversed order. Both dietary regimens will result in 8-hr eating period and 16-hr fasting period during the 24h day.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
31
Inclusion Criteria
  • BMI 25-35 kg/m²
Exclusion Criteria
  • prior diagnosis of type 1 or 2 diabetes
  • weight changes > 5% within past 3 months
  • current shift work or history of shift work
  • traveled across more than one time zone one month before the study
  • poor quality of sleep (PSQI score>10)
  • eating disorders, food intolerance/allergy, severe indigestion
  • Pregnant or breastfeeding
  • severe internal or psychiatric disorders or other conditions that might influence the outcome of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Late Time-Restricted FeedingLate Time-Restricted Feeding-
Early Time-Restricted FeedingEarly Time-Restricted Feeding-
Primary Outcome Measures
NameTimeMethod
Insulin sensitivity2 weeks

Assessed using Matsuda index in oral glucose tolerance test (OGTT)

Secondary Outcome Measures
NameTimeMethod
Anthropometric parameters: BMI2 weeks

BMI in kg/m\^2

Metabolic hormones and inflammatory markers2 weeks

Levels of hormones related to the glucose metabolism, hormones of appetite regulation, adipokines and inflammatory markers

Blood lipids2 weeks

Total cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol and triglycerides

Anthropometric parameters: fat and lean mass2 weeks

Fat and lean mass in kilograms assessed by bioelectrical impedance analysis

Food intake: macronutrient composition14 days

Macronutrient composition in percentage of energy intake as assessed by food records

Sleep quality and timing2 weeks (PSQI) and 14 days (ActiGraph, sleep diary)

Sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI score, which ranges from 0-21, where higher values correspond to worse sleep quality) and by the ActiGraph device; sleep timing (sleep onset and offset) as monitored using a sleep diary

Glucose tolerance, fasting glucose, and overall daily glycemic variation2 weeks (OGTT) and 14 days (CGM)

Assessed by glucose area under the curve in OGTT and using a continuous glucose monitoring (CGM)

Oxidative stress markers2 weeks

Malondialdehyde, 3-nitrotyrosine, and protein carbonyls

Food intake: eating times14 days

Eating times in hours and minutes as assessed by food records

Food intake: calorie intake14 days

Calorie intake in kilocalories as assessed by food records

Physical activity14 days

24-h physical activity as monitored by an ActiGraph device

Anthropometric parameters: waist circumference2 weeks

Waist circumference in centimeters

Blood pressure2 weeks

Systolic and diastolic blood pressure

Liver enzymes2 weeks

γ-glutamyltransferase (GGT), aspartate aminotransferase (ALT), and alanine aminotransferase (AST)

Anthropometric parameters: body weight2 weeks

Body weight in kilograms

Satiety and hunger scores2 weeks

Assessed using Visual Analog Scales (VAS with a scale of 1-100, where higher values correspond to stronger satiety/hunger)

Expression of metabolic genes in adipose tissue2 weeks

RNA-Seq analysis of subcutaneous adipose tissue samples

Social and economic decision behaviour2 weeks

Assessed by computer tests together with the Barratt Impulsiveness Scale short version (BIS-15 with a score between 15 and 60, where higher values correspond to higher impulsiveness) and the UCLA Loneliness Scale (with a score between 20 and 100, where higher values correspond to higher subjectively perceived loneliness)

Trial Locations

Locations (1)

German Institute of Human Nutrition Potsdam-Rehbruecke

🇩🇪

Nuthetal, Germany

© Copyright 2025. All Rights Reserved by MedPath